Results 231 to 240 of about 869,733 (343)

Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2

, 2020
Xiaoqiang Huang, Chengxin Zhang, Robin Pearce, Gilbert S. Omenn, Yang Zhang   +4 more
openalex   +1 more source

SARS-CoV-2 specific antibody responses in COVID-19 patients [PDF]

, 2020
Nisreen M.A. Okba, Marcel A. Müller, Wentao Li, Chunyan Wang, Corine H. GeurtsvanKessel, Victor M. Corman, Mart M. Lamers, Reina S. Sikkema, Erwin de Bruin, Felicity Chandler, Yazdan Yazdanpanah, Quentin Le Hingrat, Diane Descamps, Nadhira Houhou‐Fidouh, Chantal Reusken, Berend‐Jan Bosch, Christian Drosten, Marion Koopmans, Bart L. Haagmans   +18 more
openalex   +1 more source

HSP60 and SARS-CoV-2: Les Liaisons Dangereuses. [PDF]

Biology (Basel)
Carista A, Gratie MI, Cappello F, Burgio S.   +3 more
europepmc   +1 more source

A potential strategy for improving offspring behavior in maternal immune activation: Amantadine‐mediated suppression of neuroinflammation

Animal Models and Experimental Medicine, EarlyView.
Amantadine (AMA) regulates neurocyte apoptosis and inhibits neurocyte inflammation to prevent maternal immune activation (MIA) from affecting offspring behavior. Abstract Background Maternal viral infection during pregnancy can lead to maternal immune activation (MIA), increasing the risk of neurodevelopmental disorders in offspring.
Jianfei Wu, Yu Liu, Binglong Wang, Yilin Wang, Bo Liu, Youguo Tan, Duanfang Cai, Kezhi Liu, Daixu Wei   +8 more
wiley   +1 more source

Phosphorylation modulates liquid-liquid phase separation of the SARS-CoV-2 N protein

, 2020
Christopher R. Carlson, Jonathan B Asfaha, Chloe M. Ghent, Conor J Howard, Nairi Hartooni, David O. Morgan   +5 more
openalex   +1 more source

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Cell, 2020
Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen-Chun Liu, S. Uhl, D. Hoagland, Rasmus Møller, Tristan X. Jordan, K. Oishi, M. Panis, D. Sachs, Taia T. Wang, R. Schwartz, Jean K. Lim, R. Albrecht, B. tenOever   +14 more
semanticscholar   +1 more source

Silica Nanoparticles as Multifunctional Platforms for Vaccine Delivery and Immune Modulation in Infectious Diseases

Advanced NanoBiomed Research, EarlyView.
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez, Julio García‐Cordero, Gabriela Navarro‐Tovar, Leticia Cedillo‐Barrón   +3 more
wiley   +1 more source

SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice

, 2020
Jeroen Pollet, Wen‐Hsiang Chen, Leroy Versteeg, Brian Keegan, Bin Zhan, Junfei Wei, Zhuyun Liu, Jungsoon Lee, Rahki Kundu, Rakesh Adhikari, Cristina Poveda, María José Villar, Ana Carolina de Araújo Leão, Joanne Altieri Rivera, Zoha Momin, Portia M. Gillespie, Jason T. Kimata, Ulrich Strych, Peter J. Hotez, María Elena Bottazzi   +19 more
openalex   +1 more source

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature, 2021
Pengfei Wang, M. Nair, Lihong Liu, S. Iketani, Yang Luo, Yicheng Guo, Maple Wang, Jian Yu, Baoshan Zhang, P. Kwong, B. Graham, J. Mascola, Jennifer Y. Chang, M. Yin, M. Sobieszczyk, C. Kyratsous, L. Shapiro, Zizhang Sheng, Yaoxing Huang, D. Ho   +19 more
semanticscholar   +1 more source

Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission. [PDF]

Proc Natl Acad Sci U S A
Hsu CC, Chamblee M, Ye C, Shamseldin MM, Yoo SJ, Li P, Zhang Y, Liu Y, Hall JM, Xu J, Miao H, Thongpan I, K C M, Liang X, Yount JS, Peeples ME, Boyaka PN, Dubey P, Martinez-Sobrido L, Liu SL, Li J.   +20 more
europepmc   +1 more source